Breztri Aerosphere Alternatives Compared
| Breztri Aerosphere (budesonide / formoterol / glycopyrrolate) | Nucala (mepolizumab) | Symbicort (budesonide / formoterol) |
|
|---|
| Breztri Aerosphere (budesonide / formoterol / glycopyrrolate) | Nucala (mepolizumab) | Symbicort (budesonide / formoterol) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for COPD - Maintenance, COPD. Breztri Aerosphere may also be used for purposes not listed in this medication guide. |
Prescription only
Nucala is a biologic that works by blocking the action of IL-5 which is the main cytokine responsible for the survival and production of eosinophils. Nucala may be used to treat severe eosinophilic... View more |
Prescription only
Symbicort is used to treat asthma in adults and children 6 years of age and older, and for the maintenance treatment of airflow obstruction and to reduce exacerbations in COPD. It is a combination... View more |
Related suggestions COPD
COPD, Maintenance
Popular comparisons
|
|||||||||||||||||||||||
| More about Breztri Aerosphere (budesonide / formoterol / glycopyrrolate) | More about Nucala (mepolizumab) | More about Symbicort (budesonide / formoterol) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Breztri Aerosphere has an average rating of 7.0 out of 10 from a total of 134 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 13% reported a negative effect. |
Nucala has an average rating of 7.3 out of 10 from a total of 100 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 16% reported a negative effect. |
Symbicort has an average rating of 6.6 out of 10 from a total of 228 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 26% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
View all Breztri Aerosphere side effects |
View all Nucala side effects |
View all Symbicort side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
N/A |
||||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Breztri Aerosphere prices |
View all Nucala prices |
View all Symbicort prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
|
N/A |
N/A |
Other budesonide / formoterol brands include: Breyna | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
N/A |
528 hours |
7.9 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category N
Not classified
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 970 drugs are known to interact with Breztri Aerosphere:
|
A total of 27 drugs are known to interact with Nucala:
|
A total of 859 drugs are known to interact with Symbicort:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
July 23, 2020 |
November 04, 2015 |
July 21, 2006 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
||||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.